MDLN vs SGC
MDLN: Medline is a leading global manufacturer and distributor of medical supplies and clinical solutions serving healthcare providers across the care continuum. SGC: A diversified provider of branded promotional products, healthcare apparel, and business process outsourcing services.
Side-by-side fundamentals
| Metric | MDLN | SGC | Edge |
|---|---|---|---|
| Price as of 2026-10-09 close | $36.26 | $13.05 | |
| Market cap | $47.7B | $208M | |
| P/E as of 2026-10-09 | 43.00 | 23.74 | SGC lower |
| Net margin FY2025, SEC XBRL | +4.1% | +1.2% | MDLN higher |
| Gross margin FY2025, SEC XBRL | +26.4% | +37.6% | SGC higher |
| Operating margin FY2025, SEC XBRL | +7.8% | n/a | |
| ROE FY2025, SEC XBRL | +10.8% | +3.6% | MDLN higher |
| ROA FY2025, SEC XBRL | +3.0% | +1.7% | MDLN higher |
| Debt / equity as of 2026-09-03 | 1.09 | 0.42 | SGC lower |
| Revenue growth (YoY) as of 2026-09-03 | +11.6% | -0.4% | MDLN higher |
| Revenue CAGR (3y) SEC XBRL | +10.6% | -0.7% | MDLN higher |
| Dividend yield as of 2026-09-02 | n/a | +4.5% | |
| Dividend streak (yrs) SEC XBRL | 0 | 7 | SGC higher |
| Beta as of 2026-09-03 | 0.61 | 0.93 | |
| 1-year return as of 2026-10-09 close | n/a | +26.8% |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.